Experimental intestinal malabsorption states and their relation to clinical syndromes.
D000818:Animals; D001692:Biological Transport; D002446:Celiac Disease / Q000209:etiology; D003078:Colchicine; D004285:Dogs; D005493:Folic Acid Antagonists; D005983:Glutens; D006168:Guinea Pigs; D006801:Humans; D000860:Hypoxia / Q000150:complications; D066298:In Vitro Techniques; D007408:Intestinal Absorption / Q000187:drug effects; D007413:Intestinal Mucosa / Q000187:drug effects / Q000201:enzymology; D007422:Intestines / Q000528:radiation effects; D007511:Ischemia / Q000150:complications; D008247:Lysosomes / Q000201:enzymology; D008286:Malabsorption Syndromes / Q000139:chemically induced*; D051379:Mice; D008938:Mitosis / Q000187:drug effects / Q000528:radiation effects; D009355:Neomycin; D011504:Protein-Losing Enteropathies / Q000139:chemically induced; D011833:Radiation Injuries, Experimental / Q000150:complications; D051381:Rats; D012771:Shock, Hemorrhagic / Q000150:complications; D013552:Swine; D014308:Triparanol
D005493:Folic Acid Antagonists; D014308:Triparanol; D005983:Glutens; D009355:Neomycin; D003078:Colchicine